KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to -$352.4 million.

  • Oscar Health's Net Income towards Common Stockholders fell 12992.07% to -$352.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$442.9 million, marking a year-over-year decrease of 179558.21%. This contributed to the annual value of -$442.9 million for FY2025, which is 179558.21% down from last year.
  • Latest data reveals that Oscar Health reported Net Income towards Common Stockholders of -$352.4 million as of Q4 2025, which was down 12992.07% from -$137.5 million recorded in Q3 2025.
  • Oscar Health's 5-year Net Income towards Common Stockholders high stood at $275.5 million for Q1 2025, and its period low was -$352.4 million during Q4 2025.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$100.5 million (2021), whereas its average is -$93.4 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first soared by 54787.02% in 2024, then tumbled by 50575.9% in 2025.
  • Oscar Health's Net Income towards Common Stockholders (Quarter) stood at -$197.7 million in 2021, then fell by 14.57% to -$226.6 million in 2022, then skyrocketed by 33.86% to -$149.8 million in 2023, then fell by 2.3% to -$153.3 million in 2024, then plummeted by 129.92% to -$352.4 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$352.4 million for Q4 2025, versus -$137.5 million for Q3 2025 and -$228.5 million for Q2 2025.